U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07462793) titled 'COntinuous Glucose Monitoring in nEwborns of Mothers With Insulin-Treated Gestational Diabetes Mellitus' on Feb. 27.
Brief Summary: The purpose of this study is to determine whether continuous glucose monitoring (CGM) improves the detection and management of neonatal hypoglycaemia in newborns of mothers with insulin-treated gestational diabetes.
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Neonatal Hypoglycemia
Gestational Diabetes Mellitus (GDM)
Intervention:
DEVICE: Dexcom ONE Continuous Glucose Monitoring System
The Dexcom ONE continuous glucose monitoring system is applied to all participants. Foll...